Terms: = Lymphoma AND FUBP1, FBP, 8880, ENSG00000162613, FUBP
15 results:
1. Deep learning for [
Häggström I; Leithner D; Alvén J; Campanella G; Abusamra M; Zhang H; Chhabra S; Beer L; Haug A; Salles G; Raderer M; Staber PB; Becker A; Hricak H; Fuchs TJ; Schöder H; Mayerhoefer ME
Lancet Digit Health; 2024 Feb; 6(2):e114-e125. PubMed ID: 38135556
[TBL] [Abstract] [Full Text] [Related]
2. Multimodal radiomics and nomogram-based prediction of axillary lymph node metastasis in breast cancer: An analysis considering optimal peritumoral region.
Duan Y; Chen X; Li W; Li S; Zhang C
J Clin Ultrasound; 2023 Sep; 51(7):1231-1241. PubMed ID: 37410710
[TBL] [Abstract] [Full Text] [Related]
3. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Dicanio M; Giaccherini M; Clay-Gilmour A; Macauda A; Sainz J; Machiela MJ; Rybicka-Ramos M; Norman AD; Tyczyńska A; Chanock SJ; Barington T; Kumar SK; Bhatti P; Cozen W; Brown EE; Suska A; Haastrup EK; Orlowski RZ; Dudziński M; Garcia-Sanz R; Kruszewski M; Martinez-Lopez J; Beider K; Iskierka-Jazdzewska E; Pelosini M; Berndt SI; Raźny M; Jamroziak K; Rajkumar SV; Jurczyszyn A; Vangsted AJ; Collado PG; Vogel U; Hofmann JN; Petrini M; Butrym A; Slager SL; Ziv E; Subocz E; Giles GG; Andersen NF; Mazur G; Watek M; Lesueur F; Hildebrandt MAT; Zawirska D; Ebbesen LH; Marques H; Gemignani F; Dumontet C; Várkonyi J; Buda G; Nagler A; Druzd-Sitek A; Wu X; Kadar K; Camp NJ; Grzasko N; Waller RG; Vachon C; Canzian F; Campa D
Int J Cancer; 2023 Jan; 152(2):239-248. PubMed ID: 36082445
[TBL] [Abstract] [Full Text] [Related]
4. Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma.
Fleming JL; Pugh SL; Fisher BJ; Lesser GJ; Macdonald DR; Bell EH; McElroy JP; Becker AP; Timmers CD; Aldape KD; Rogers CL; Doyle TJ; Werner-Wasik M; Bahary JP; Yu HM; D'Souza DP; Laack NN; Sneed PK; Kwok Y; Won M; Mehta MP; Chakravarti A
JCO Precis Oncol; 2021; 5():. PubMed ID: 34589661
[TBL] [Abstract] [Full Text] [Related]
5. Association of Leukemia Target Genes
Li J; Zhang W; Liu W; Rong J; Chen Y; Gu W; Zhang W
Cancer Genomics Proteomics; 2019; 16(5):333-344. PubMed ID: 31467227
[TBL] [Abstract] [Full Text] [Related]
6. Interplay between transcription regulators RUNX1 and fubp1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.
Debaize L; Jakobczyk H; Avner S; Gaudichon J; Rio AG; Sérandour AA; Dorsheimer L; Chalmel F; Carroll JS; Zörnig M; Rieger MA; Delalande O; Salbert G; Galibert MD; Gandemer V; Troadec MB
Nucleic Acids Res; 2018 Nov; 46(21):11214-11228. PubMed ID: 30500954
[TBL] [Abstract] [Full Text] [Related]
7. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
[TBL] [Abstract] [Full Text] [Related]
8. [Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate].
Kitamura K; Matsushita K; Kobayashi S; Ishige T; Semba T; Kimura A; Kazami T; Ohyama M; Itoga S; Beppu M; Nishimura M; Satoh M; Nomura F
Rinsho Byori; 2015 Sep; 63(9):1091-102. PubMed ID: 26731899
[TBL] [Abstract] [Full Text] [Related]
9. [Alternative Splicing Detection as Biomarker Candidates for Cancer Diagnosis and Treatment with Establishment of Clinical Biobank in Chiba University].
Matsushita K; Itoga S; Nishimura M; Furuta K; Nomura F
Rinsho Byori; 2015 Mar; 63(3):347-60. PubMed ID: 26524858
[TBL] [Abstract] [Full Text] [Related]
10. Use of Model-Based Iterative Reconstruction (MBIR) in reduced-dose CT for routine follow-up of patients with malignant lymphoma: dose savings, image quality and phantom study.
Hérin E; Gardavaud F; Chiaradia M; Beaussart P; Richard P; Cavet M; Deux JF; Haioun C; Itti E; Rahmouni A; Luciani A
Eur Radiol; 2015 Aug; 25(8):2362-70. PubMed ID: 25749813
[TBL] [Abstract] [Full Text] [Related]
11. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
[TBL] [Abstract] [Full Text] [Related]
12. Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma.
Sen HN; Chan CC; Byrnes G; Fariss RN; Nussenblatt RB; Buggage RR
Ocul Immunol Inflamm; 2008; 16(1):29-33. PubMed ID: 18379939
[TBL] [Abstract] [Full Text] [Related]
13. A comparison of human and model observers in multislice LROC studies.
Gifford HC; King MA; Pretorius PH; Wells RG
IEEE Trans Med Imaging; 2005 Feb; 24(2):160-9. PubMed ID: 15707242
[TBL] [Abstract] [Full Text] [Related]
14. LROC analysis of detector-response compensation in SPECT.
Gifford HC; King MA; Wells RG; Hawkins WG; Narayanan MV; Pretorius PH
IEEE Trans Med Imaging; 2000 May; 19(5):463-73. PubMed ID: 11021689
[TBL] [Abstract] [Full Text] [Related]
15. Binding of lectins to human leukaemic cells.
Slesak B; Bogusławska-Jaworska J; Pejcz J; Harłozińska A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):251-9. PubMed ID: 2475405
[TBL] [Abstract] [Full Text] [Related]
